Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Elicio Therapeutics (ELTX) Return on Equity (2020 - 2026)

Elicio Therapeutics filings provide 4 years of Return on Equity readings, the most recent being 0.03% for Q4 2023.

  • On a quarterly basis, Return on Equity fell 3.0% to 0.03% in Q4 2023 year-over-year; TTM through Dec 2023 was 0.03%, a 3.0% decrease, with the full-year FY2023 number at 0.01%, changed 0.0% from a year prior.
  • Return on Equity hit 0.03% in Q4 2023 for Elicio Therapeutics, down from 0.02% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.08% in Q4 2021 to a low of 0.63% in Q1 2021.
  • Median Return on Equity over the past 4 years was 0.0% (2023), compared with a mean of 0.05%.
  • The widest YoY moves for Return on Equity: up 63bps in 2022, down -7bps in 2022.
  • Elicio Therapeutics' Return on Equity stood at 0.01% in 2020, then soared by 990bps to 0.08% in 2021, then crashed by -96bps to 0.0% in 2022, then tumbled by -944bps to 0.03% in 2023.
  • The last three reported values for Return on Equity were 0.03% (Q4 2023), 0.02% (Q3 2023), and 0.01% (Q2 2023) per Business Quant data.